194 related articles for article (PubMed ID: 16586470)
1. Use of prescription medications with a potential for fetal harm among pregnant women.
Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
[TBL] [Abstract][Full Text] [Related]
2. Prescription drug use in pregnancy.
Andrade SE; Gurwitz JH; Davis RL; Chan KA; Finkelstein JA; Fortman K; McPhillips H; Raebel MA; Roblin D; Smith DH; Yood MU; Morse AN; Platt R
Am J Obstet Gynecol; 2004 Aug; 191(2):398-407. PubMed ID: 15343213
[TBL] [Abstract][Full Text] [Related]
3. National patterns of medication use during pregnancy.
Lee E; Maneno MK; Smith L; Weiss SR; Zuckerman IH; Wutoh AK; Xue Z
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):537-45. PubMed ID: 16700083
[TBL] [Abstract][Full Text] [Related]
4. Prescription of teratogenic medications in United States ambulatory practices.
Schwarz EB; Maselli J; Norton M; Gonzales R
Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
[TBL] [Abstract][Full Text] [Related]
5. Outpatient use of cardiovascular drugs during pregnancy.
Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619
[TBL] [Abstract][Full Text] [Related]
6. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.
Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228
[TBL] [Abstract][Full Text] [Related]
7. Provision of potentially teratogenic medications to female veterans of childbearing age.
Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
[TBL] [Abstract][Full Text] [Related]
8. Patterns of medication use during pregnancy in rheumatoid arthritis.
Kuriya B; Hernández-Díaz S; Liu J; Bermas BL; Daniel G; Solomon DH
Arthritis Care Res (Hoboken); 2011 May; 63(5):721-8. PubMed ID: 21557526
[TBL] [Abstract][Full Text] [Related]
9. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
[TBL] [Abstract][Full Text] [Related]
10. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319
[TBL] [Abstract][Full Text] [Related]
11. Prescriptions filled during pregnancy for drugs with the potential of fetal harm.
Kulaga S; Zargarzadeh AH; Bérard A
BJOG; 2009 Dec; 116(13):1788-95. PubMed ID: 19832828
[TBL] [Abstract][Full Text] [Related]
12. Assessment of drug use among pregnant women in Addis Ababa, Ethiopia.
Kebede B; Gedif T; Getachew A
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):462-8. PubMed ID: 19334033
[TBL] [Abstract][Full Text] [Related]
13. Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database.
Hardy JR; Leaderer BP; Holford TR; Hall GC; Bracken MB
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):555-64. PubMed ID: 16767799
[TBL] [Abstract][Full Text] [Related]
14. FDA drug prescribing warnings: is the black box half empty or half full?
Wagner AK; Chan KA; Dashevsky I; Raebel MA; Andrade SE; Lafata JE; Davis RL; Gurwitz JH; Soumerai SB; Platt R
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):369-86. PubMed ID: 16294363
[TBL] [Abstract][Full Text] [Related]
15. Physician characteristics and prescription drug use during pregnancy: a population-based study.
Weng SS; Chen YH; Lin CC; Keller JJ; Wang IT; Lin HC
Ann Epidemiol; 2013 Feb; 23(2):54-9. PubMed ID: 23218810
[TBL] [Abstract][Full Text] [Related]
16. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.
Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Straus SM; Stricker BH
BJOG; 2015 Jul; 122(8):1119-29. PubMed ID: 25316196
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data.
Raebel MA; Ellis JL; Andrade SE
Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):829-36. PubMed ID: 15800957
[TBL] [Abstract][Full Text] [Related]
18. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women.
Cleary BJ; Butt H; Strawbridge JD; Gallagher PJ; Fahey T; Murphy DJ
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):408-17. PubMed ID: 20099251
[TBL] [Abstract][Full Text] [Related]
19. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study.
Viktil KK; Engeland A; Furu K
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):737-42. PubMed ID: 19504626
[TBL] [Abstract][Full Text] [Related]
20. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
